Stock listing

NASDAQ:LGVN Longeveron Inc. Stock

Home listing (NASDAQ) of Longeveron Inc.

Follow Longeveron Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:LGVN

$1.67 USD -0.08 (-4.6%)

Close on Oct 30, 2026

Past year -80.1% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$1.58 – $1.80 USDOct 30, 2026
Volume
80,744 sharesOct 30, 2026
Market cap
$5.08M USDAt the close on Oct 30, 2026 · price × 3.04M shares outstanding
52-week range
$1.31 – $12.30 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$289,175 USDMedian day 55,100 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Longeveron Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LGVN · Home$1.67 USD-0.08 (-4.6%)80,744$1.78$1.80$1.581$1.75Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:LGVN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.67-0.08-4.6%$1.78$1.80$1.58180,744
$1.75-0.03-1.7%$1.731$1.83$1.73162,772
$1.78+0.05+2.9%$1.74$1.83$1.7182,340
$1.73+0.125+7.8%$1.62$1.76$1.6290,730
$1.605+0.005+0.3%$1.55$1.86$1.5091,043
$1.60+0.01+0.6%$1.58$1.68$1.47664,400
$1.59+0.16+11.2%$1.41$1.64$1.4173,500
$1.43-0.07-4.7%$1.49$1.53$1.4282,100
$1.50+0.11+7.9%$1.40$1.52$1.3650,300
$1.390.000.0%$1.40$1.507$1.3156,400
$1.39-0.11-7.3%$1.47$1.491$1.3666,000
$1.50-0.23-13.3%$1.68$1.71$1.37150,400
$1.73-0.42-19.5%$2.11$2.11$1.69158,600
$2.15-0.30-12.2%$2.42$2.445$2.1460,500
$2.45-0.03-1.2%$2.49$2.55$2.4234,700
$2.48+0.11+4.6%$2.40$2.60$2.3458,400
$2.37-0.07-2.9%$2.45$2.57$2.3277,200
$2.44+0.09+3.8%$2.33$2.48$2.3358,100
$2.35-0.16-6.4%$2.50$2.50$2.3483,600
$2.51-0.07-2.7%$2.59$2.692$2.5144,200
$2.58-0.01-0.4%$2.56$2.675$2.5420,800
$2.59-0.10-3.7%$2.72$2.74$2.5272,900
$2.69-0.03-1.1%$2.73$2.80$2.6155,000
$2.72+0.09+3.4%$2.68$2.74$2.60455,200
$2.63-0.18-6.4%$2.79$2.79$2.62297,000
$2.81-0.10-3.4%$2.89$2.95$2.7650,100
$2.91+0.31+11.9%$2.54$2.97$2.50172,000
$2.60-0.12-4.4%$2.68$2.76$2.5362,300
$2.72+0.27+11.0%$2.47$2.83$2.32233,500
$2.45-0.04-1.6%$2.49$2.54$2.33171,500
$2.49-0.22-8.1%$2.80$2.80$2.30522,900
$2.71-3.97-59.4%$3.23$3.35$2.701,435,500
$6.68-0.18-2.6%$6.83$7.15$6.52316,600
$6.86-0.06-0.9%$6.89$7.10$6.6544,200
$6.92-0.41-5.6%$7.195$7.60$6.9261,800
$7.33+0.69+10.4%$6.79$7.36$6.6467,300
$6.64+0.06+0.9%$6.52$6.80$6.5059,600
$6.58-0.07-1.1%$6.58$6.75$6.5129,400
$6.65-0.16-2.3%$6.78$6.90$6.5650,100
$6.81+0.23+3.5%$6.54$6.88$6.5340,400
$6.58-0.20-2.9%$6.82$7.04$6.5543,900
$6.78+0.03+0.4%$6.67$6.948$6.6536,000
$6.75-0.15-2.2%$6.86$7.045$6.6132,500
$6.90+0.18+2.7%$6.75$7.299$6.51104,900
$6.72-0.08-1.2%$6.80$7.25$6.5579,800
$6.80-0.233-3.3%$7.06$7.28$6.59130,237
$7.033+0.233+3.4%$6.86$7.40$6.766,660
$6.80-1.578-18.8%$7.30$7.345$6.5015,922
$8.378-0.071-0.8%$8.50$8.70$8.0499,396
$8.449+0.167+2.0%$8.60$8.70$8.2317,705
$8.282+0.059+0.7%$8.40$8.90$8.1766,187
$8.223+0.351+4.5%$8.115$8.80$8.0011,093
$7.872-0.328-4.0%$8.00$8.30$7.6635,049
$8.20+0.801+10.8%$7.50$8.40$7.4012,265
$7.399+0.423+6.1%$7.021$7.549$7.0022,988
$6.976-0.493-6.6%$6.701$7.299$6.705,347
$7.469+0.548+7.9%$7.149$7.90$7.0459,229
$6.921-0.442-6.0%$7.40$7.88$6.8179,141
$7.363-0.297-3.9%$7.70$7.978$7.2055,218
$7.66-0.075-1.0%$7.77$8.00$7.5014,178
$7.735+0.464+6.4%$7.561$7.898$7.502,206
$7.271-0.15-2.0%$7.498$7.829$7.202,293
$7.421+0.101+1.4%$7.50$8.00$7.357,780
$7.32+0.305+4.3%$7.20$7.57$7.102,935
$7.015+0.262+3.9%$7.00$7.675$6.856,532
$6.753+0.803+13.5%$5.95$6.931$5.8614,849
Ticker
NASDAQ:LGVN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Longeveron (NASDAQ:LGVN) Q2 2026 Earnings Call

    Wed, Aug 12, 2026 · 4:30 PM ET

    Watch Transcript

  • Longeveron (NASDAQ:LGVN) Q1 2026 Earnings Call

    Wed, May 13, 2026 · 4:30 PM ET

    Watch Transcript

  • Longeveron (NASDAQ:LGVN) Q4 2025 Earnings Call

    Tue, Mar 17, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Longeveron Announces Engagement of Lucid Capital Markets

Oct 28, 2026

Closed $1.78 (+2.9%) on Oct 28, 2026

Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Oct 26, 2026

Closed $1.61 (+0.3%) on Oct 26, 2026

Longeveron to Participate in Three Longevity/Aging Investment Conferences

Sep 30, 2026

Closed $2.59 (-3.7%) on Oct 1, 2026

Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Sep 3, 2026

Closed $6.58 (-2.9%) on Sep 3, 2026

Longeveron Appoints Nirav Jhaveri as Chief Financial Officer

Aug 19, 2026

Closed $8.28 (+0.7%) on Aug 20, 2026

Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

Aug 12, 2026

Closed $6.98 (-6.6%) on Aug 13, 2026

Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition

Aug 11, 2026

Closed $6.92 (-6.0%) on Aug 11, 2026

Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026

Aug 3, 2026

Closed $7.42 (+1.4%) on Aug 4, 2026

Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors

Jul 23, 2026

Closed $6.07 (-3.1%) on Jul 23, 2026

Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease

Jul 13, 2026

Closed $6.31 (-6.5%) on Jul 13, 2026

All Longeveron Inc. news

Decks

Longeveron Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
40 in the last 12 months · 180 in all · newest Oct 28, 2026 · oldest 2021
Calls
20 calls with a replay · 20 with a transcript · latest Aug 12, 2026
Decks
12 decks · latest Aug 12, 2026

Where Longeveron Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:LGVN · Home listing · This pageNASDAQUnited StatesUSD
BOATS:LGVNBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Longeveron Inc.